ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,581Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 5176

$1.45M Total Retail Price of All Prescriptions

Rank: 114 out of 5176

729 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 729 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 729 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 17,474 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,049 690 1 1
WARFARIN SODIUM 1,016 793 2 13
MIRTAZAPINE 971 833 3 45
LEVOTHYROXINE SODIUM 878 626 4 4
FUROSEMIDE 824 561 5 8
METOPROLOL TARTRATE 771 581 6 6
LISINOPRIL 718 514 7 5
DIVALPROEX SODIUM 622 454 8 104
RISPERIDONE 581 414 9 78
METFORMIN HCL 507 321 10 7
CITALOPRAM HBR 493 368 11 31
QUETIAPINE FUMARATE 473 314 12 75
BENZTROPINE MESYLATE 369 226 R 13 201
AMLODIPINE BESYLATE 356 267 14 2
TRAZODONE HCL 349 270 15 71
GABAPENTIN 329 160 16 21
SERTRALINE HCL 321 245 17 30
HALOPERIDOL 301 223 18 145
OXYCODONE HCL 299 107 S2 19 121
OLANZAPINE 281 164 20 140
POTASSIUM CHLORIDE 278 188 21 34
RANITIDINE HCL 273 171 22 36
LACTULOSE 262 142 23 87
DOXAZOSIN MESYLATE 248 192 24 103
ALBUTEROL SULFATE 246 177 25 99
OMEPRAZOLE 227 127 26 3
SEROQUEL 224 137 27 166
ATENOLOL 221 165 28 12
SANTYL 215 151 29 124
JANTOVEN 206 132 30 106
POLYETHYLENE GLYCOL 3350 206 118 30 74
CARBIDOPA-LEVODOPA 202 155 32 98
LANTUS 202 87 32 66
NOVOLIN R 202 123 32 191
ZOLPIDEM TARTRATE 200 130 35 17
PREDNISONE 194 154 36 52
NYSTATIN-TRIAMCINOLONE 188 107 37 142
SPIRONOLACTONE 188 90 37 88
IPRATROPIUM BROMIDE 171 131 39 135
JANUVIA 171 102 39 25
ENALAPRIL MALEATE 170 132 41 22
CARVEDILOL 167 140 42 24
FAMOTIDINE 163 121 43 58
DIGOXIN 159 137 44 56
DIVALPROEX SODIUM ER 157 61 45 270
GLIPIZIDE 155 116 46 63
VENLAFAXINE HCL 152 71 47 309
CIPROFLOXACIN HCL 151 112 48 84
LEVETIRACETAM 149 87 49 92
OXYCODONE-ACETAMINOPHEN 143 67 S2 50 101
FINASTERIDE 141 87 51 69
NAMENDA 139 121 52 47
BACLOFEN 133 23 53 173
NOVOLIN N 130 56 54 304
IBUPROFEN 127 67 55 72
TAMSULOSIN HCL 124 61 56 20
MUPIROCIN 123 83 57 182
VALPROIC ACID 122 85 58 195
CYMBALTA 121 70 59 90
LAMOTRIGINE 121 12 59 289
ISOSORBIDE MONONITRATE ER 118 84 61 44
CLOPIDOGREL 109 84 62 26
PAROXETINE HCL 108 67 63 93
FLUOXETINE HCL 107 39 64 132
CYCLOBENZAPRINE HCL 106 69 R 65 143
DOXYCYCLINE HYCLATE 106 71 65 247
ADVAIR DISKUS 105 68 67 32
ESCITALOPRAM OXALATE 104 62 68 89
SILVER SULFADIAZINE 100 45 69 207
DONEPEZIL HCL 99 76 70 28
CLONIDINE HCL 99 67 70 79
AMOX TR-POTASSIUM CLAVULANATE 97 44 72 141
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 53 73 181
CLOZAPINE 94 24 74 269
ABILIFY 93 75 75 273
HYDROMORPHONE HCL 89 24 S2 76 382
LATANOPROST 87 67 77 185
LIDOCAINE HCL 84 57 78 325
GLIMEPIRIDE 83 40 79 37
PLAVIX 82 67 80 29
CEFTRIAXONE 81 51 81 338
METOLAZONE 80 40 82 271
ATORVASTATIN CALCIUM 78 65 83 9
LOSARTAN POTASSIUM 78 71 83 14
TRAMADOL HCL 76 64 85 40
SPIRIVA 75 58 86 54
CARBAMAZEPINE 75 36 86 302
OXYBUTYNIN CHLORIDE 75 27 86 227
ZYPREXA 75 46 86 548
HYDRALAZINE HCL 73 62 90 73
AMIODARONE HCL 70 61 91 281
VANCOMYCIN HCL 69 56 92 394
MIACALCIN 66 0 10 93 652
FLUOCINONIDE 63 46 94 165
SINGULAIR 62 41 95 62
LITHIUM CARBONATE 62 27 95 393
GENTAMICIN SULFATE 59 30 97 431
TOBRAMYCIN 59 42 97 563
AMANTADINE 59 42 97 390
KLOR-CON M20 57 26 100 129
KETOCONAZOLE 57 26 100 233
ALLOPURINOL 56 45 102 41
NYSTATIN 55 41 103 168
FENTANYL 54 40 S2 104 172
IPRATROPIUM-ALBUTEROL 53 31 105 138
METOPROLOL SUCCINATE 53 52 105 11
ENDOCET 53 39 S2 105 246
TOPIRAMATE 51 0 108 314
NITROFURANTOIN MONO-MACRO 50 29 109 350
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.